全文获取类型
收费全文 | 2572176篇 |
免费 | 189612篇 |
国内免费 | 7548篇 |
专业分类
耳鼻咽喉 | 34421篇 |
儿科学 | 85044篇 |
妇产科学 | 71614篇 |
基础医学 | 361548篇 |
口腔科学 | 69711篇 |
临床医学 | 233248篇 |
内科学 | 511677篇 |
皮肤病学 | 62450篇 |
神经病学 | 212264篇 |
特种医学 | 99946篇 |
外国民族医学 | 736篇 |
外科学 | 386207篇 |
综合类 | 50277篇 |
现状与发展 | 5篇 |
一般理论 | 973篇 |
预防医学 | 194798篇 |
眼科学 | 57027篇 |
药学 | 187698篇 |
8篇 | |
中国医学 | 5157篇 |
肿瘤学 | 144527篇 |
出版年
2019年 | 20806篇 |
2018年 | 29468篇 |
2017年 | 22747篇 |
2016年 | 26380篇 |
2015年 | 29646篇 |
2014年 | 40678篇 |
2013年 | 60686篇 |
2012年 | 80603篇 |
2011年 | 84837篇 |
2010年 | 51227篇 |
2009年 | 49349篇 |
2008年 | 79351篇 |
2007年 | 84148篇 |
2006年 | 85860篇 |
2005年 | 82001篇 |
2004年 | 78981篇 |
2003年 | 76104篇 |
2002年 | 73383篇 |
2001年 | 128276篇 |
2000年 | 131085篇 |
1999年 | 109844篇 |
1998年 | 29660篇 |
1997年 | 26226篇 |
1996年 | 26466篇 |
1995年 | 27265篇 |
1994年 | 24964篇 |
1993年 | 23312篇 |
1992年 | 85104篇 |
1991年 | 81583篇 |
1990年 | 78775篇 |
1989年 | 76044篇 |
1988年 | 69449篇 |
1987年 | 67986篇 |
1986年 | 63532篇 |
1985年 | 60491篇 |
1984年 | 44902篇 |
1983年 | 37860篇 |
1982年 | 22378篇 |
1981年 | 19922篇 |
1979年 | 38915篇 |
1978年 | 27381篇 |
1977年 | 23174篇 |
1976年 | 21429篇 |
1975年 | 22767篇 |
1974年 | 26752篇 |
1973年 | 25340篇 |
1972年 | 23738篇 |
1971年 | 21946篇 |
1970年 | 20160篇 |
1969年 | 19409篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Rolf Svedjeholm Gabriele Ferrari Farkas Vanky Örjan Friberg Jonas Holm 《Acta anaesthesiologica Scandinavica》2023,67(10):1373-1382
Background
Glutamate plays a key role for post-ischaemic recovery of myocardial metabolism. According to post hoc analyses of the two GLUTAMICS trials, patients without diabetes benefit from glutamate with less myocardial dysfunction after coronary artery bypass surgery (CABG). Copeptin reflects activation of the Arginine Vasopressin system and is a reliable marker of heart failure but available studies in cardiac surgery are limited. We investigated whether glutamate infusion is associated with reduced postoperative rises of plasma Copeptin (p-Copeptin) after CABG.Methods
A prespecified randomised double-blind substudy of GLUTAMICS II. Patients had left ventricular ejection fraction ≤0.30 or EuroSCORE II ≥3.0 and underwent CABG ± valve procedure. Intravenous infusion of 0.125 M L-glutamic acid or saline at 1.65 mL/kg/h was commenced 10–20 min before the release of the aortic cross-clamp and then continued for another 150 min P-Copeptin was measured preoperatively and postoperatively on day one (POD1) and day three. The primary endpoint was an increase in p-Copeptin from the preoperative level to POD1. Postoperative stroke ≤24 h and mortality ≤30 days were safety outcomes.Results
We included 181 patients of whom 48% had diabetes. The incidence of postoperative mortality ≤30 days (0% vs. 2.1%; p = .50) and stroke ≤24 h (0% vs. 3.2%; p = .25) did not differ between the glutamate group and controls. P-Copeptin increased postoperatively with the highest values recorded on POD1 without significant inter-group differences. Among patients without diabetes, p-Copeptin did not differ preoperatively but postoperative rise from preoperative level to POD1 was significantly reduced in the glutamate group (73 ± 66 vs. 115 ± 102 pmol/L; p = .02). P-Copeptin was significantly lower in the Glutamate group on POD1 (p = .02) and POD 3 (p = .02).Conclusions
Glutamate did not reduce rises of p-Copeptin significantly after moderate to high-risk CABG. However, glutamate was associated with reduced rises of p-Copeptin among patients without diabetes. These results agree with previous observations suggesting that glutamate mitigates myocardial dysfunction after CABG in patients without diabetes. Given the exploratory nature of these findings, they need to be confirmed in future studies. 相似文献2.
S. Liu A. E. Patanwala J. M. Naylor N. Levy R. Knaggs J. A. Stevens B. Bugeja D. Begley K. E. Khor E. Lau R. Allen S. Adie J. Penm 《Anaesthesia》2023,78(10):1237-1248
Modified-release opioids are often prescribed for the management of moderate to severe acute pain following total hip and knee arthroplasty, despite recommendations against their use due to increasing concerns regarding harm. The primary objective of this multicentre study was to examine the impact of modified-release opioid use on the incidence of opioid-related adverse events compared with immediate-release opioid use, among adult inpatients following total hip or knee arthroplasty. Data for total hip and knee arthroplasty inpatients receiving an opioid analgesic for postoperative analgesia during hospitalisation were collected from electronic medical records of three tertiary metropolitan hospitals in Australia. The primary outcome was the incidence of opioid-related adverse events during hospital admission. Patients who received modified with or without immediate-release opioids were matched to those receiving immediate-release opioids only (1:1) using nearest neighbour propensity score matching with patient and clinical characteristics as covariates. This included total opioid dose received. In the matched cohorts, patients given modified-release opioids (n = 347) experienced a higher incidence of opioid-related adverse events overall, compared with those given immediate-release opioids only (20.5%, 71/347 vs. 12.7%, 44/347; difference in proportions 7.8% [95%CI 2.3–13.3%]). Modified-release opioid use was associated with an increased risk of harm when used for acute pain during hospitalisation after total hip or knee arthroplasty. 相似文献
3.
4.
Rozhkov V. P. Trifonov M. I. Soroko S. I. 《Neuroscience and behavioral physiology》2022,52(3):383-394
Neuroscience and Behavioral Physiology - We present here results from analysis of the formation of brain bioelectrical activity in children and adolescents living in the northern region of Russia... 相似文献
5.
6.
7.
8.
In 2019, the scientists who discovered how cells sense and adapt to oxygen availability were awarded the Nobel Prize. This elegant sensing pathway is conserved throughout evolution, and it underpins the physiology and pathology that we, as clinicians in anaesthesia and critical care, encounter on a daily basis. The purpose of this review is to bring hypoxia-inducible factor, and the oxygen-sensing pathway as a whole, to the wider clinical community. We describe how this unifying mechanism was discovered, and how it orchestrates diverse changes such as erythropoiesis, ventilatory acclimatisation, pulmonary vascular remodelling and altered metabolism. We explore the lessons learnt from genetic disorders of oxygen sensing, and the wider implications in evolution of all animal species, including our own. Finally, we explain how this pathway is relevant to our clinical practice, and how it is being manipulated in new treatments for conditions such as cancer, anaemia and pulmonary hypertension. 相似文献
9.
Troppmair Teresa Egger J. Krösbacher A. Zanvettor A. Schinnerl A. Neumayr A. Baubin M. 《Der Anaesthesist》2022,71(4):272-280
Die Anaesthesiologie - Die Qualität eines Rettungssystems zeichnet sich auch durch den effizienten Einsatz seiner personellen und Fahrzeugressourcen aus. So können im berechtigten Fall... 相似文献
10.